EVOFEM BIOSCIENCES, INC. Payments to Acquire Held-to-maturity Securities
EVOFEM BIOSCIENCES, INC. (EVFM) reported Payments to Acquire Held-to-maturity Securities of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-04.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireHeldToMaturitySecurities · last filed 2021-03-04
- EVOFEM BIOSCIENCES, INC. payments to acquire held-to-maturity securities for the quarter ending 2020-12-31 was $0.00, a 100.00% decline year-over-year.
- EVOFEM BIOSCIENCES, INC. payments to acquire held-to-maturity securities for the quarter ending 2020-09-30 was -$536.00K, a 114.43% decline year-over-year.
- EVOFEM BIOSCIENCES, INC. payments to acquire held-to-maturity securities for the quarter ending 2020-06-30 was $441.00K.
- EVOFEM BIOSCIENCES, INC. payments to acquire held-to-maturity securities for the quarter ending 2020-03-31 was $95.00K.
- EVOFEM BIOSCIENCES, INC. payments to acquire held-to-maturity securities for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- EVOFEM BIOSCIENCES, INC. payments to acquire held-to-maturity securities for fiscal 2019 was $8.23M.
- EVOFEM BIOSCIENCES, INC. payments to acquire held-to-maturity securities for fiscal 2018 was $0.00.
| Period end | Payments to Acquire Held-to-maturity Securities 3 month | Payments to Acquire Held-to-maturity Securities 6 month | Payments to Acquire Held-to-maturity Securities 9 month | Payments to Acquire Held-to-maturity Securities 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | -$536.00K derived: sum of 2 quarters · filed 2021-03-04 | -$95.00K derived: sum of 3 quarters · filed 2021-03-04 | $0.00 10-K · filed 2021-03-04 |
| 2020-09-30 | -$536.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$95.00K derived: sum of 2 quarters · filed 2020-11-09 | $0.00 10-Q · filed 2020-11-09 | $4.52M derived: sum of 4 quarters · filed 2021-03-04 |
| 2020-06-30 | $441.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $536.00K 10-Q · filed 2020-08-04 | $5.05M derived: sum of 3 quarters · filed 2021-03-04 | $8.77M derived: sum of 4 quarters · filed 2021-03-04 |
| 2020-03-31 | $95.00K 10-Q · filed 2020-05-06 | $4.61M derived: sum of 2 quarters · filed 2021-03-04 | $8.33M derived: sum of 3 quarters · filed 2021-03-04 | $8.33M derived: sum of 4 quarters · filed 2021-03-04 |
| 2019-12-31 | $4.52M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | $8.23M derived: sum of 2 quarters · filed 2021-03-04 | $8.23M derived: sum of 3 quarters · filed 2021-03-04 | $8.23M 10-K · filed 2021-03-04 |
| 2019-09-30 | $3.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $3.71M derived: sum of 2 quarters · filed 2020-11-09 | $3.71M 10-Q · filed 2020-11-09 | $3.71M derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $0.00 10-Q · filed 2020-08-04 | $0.00 derived: sum of 3 quarters · filed 2020-08-04 | |
| 2019-03-31 | $0.00 10-Q · filed 2020-05-06 | $0.00 derived: sum of 2 quarters · filed 2020-05-06 | ||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $0.00 10-K · filed 2020-03-12 | ||
| 2018-09-30 | $0.00 10-Q · filed 2019-11-07 |